Optometrists in Pt Charlotte, FL Accepting Medicare
1 Optometrists found. Showing 1 - 1
 Jeffrey M Moore Od Pa Optometrist Medicare: Medicare Enrolled Practice Location: 1444 Tamiami Trail, 481, Pt Charlotte, FL 33948 Phone: 941-255-0588 |
News Archive
Low-molecular-weight PAHs promote conditions for cancer growth
​Tobacco smoke, diesel exhaust and oil combustion carry polycyclic aromatic hydrocarbons - PAHs that are known to cause cancer. But of these PAHs, the obviously dangerous high-molecular-weight PAHs like benzo[a]pyrene (BaP) have received the vast majority of research attention.
BioSante Pharmaceuticals reinitiates GVAX Prostate Cancer Vaccine development
BioSante Pharmaceuticals, Inc. today announced that development of its GVAX Prostate Cancer Vaccine (GVAX Prostate) for the treatment of prostate cancer has been reinitiated. Manufacturing of new GVAX Prostate is in process, regulatory steps to lift the GVAX Prostate clinical hold prior to trial initiation are being taken, and prostate cancer patients are expected to be treated in a Phase II human clinical trial beginning in the fourth quarter of 2010 at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.
OrbusNeich Medical awarded US patent for "Stent with Helical Elements"
OrbusNeich Medical, Inc., a designer, developer, manufacturer and marketer of innovative medical devices for the treatment of cardiovascular diseases, today announced that on March 23, 2010, the Company was granted U.S. Patent No. 7,682,384 B2, entitled "Stent with Helical Elements." The patent relates to an expandable stent comprised of a plurality of helical segments. The Company noted that it has identified unlicensed use by Boston Scientific Corporation of certain technologies protected under U.S. Patent No. 7,682,384 B2.
Conjuring up visual image in mind has corresponding effect on size of pupils
Conjuring up a visual image in the mind - like a sunny day or a night sky - has a corresponding effect on the size of our pupils, as if we were actually seeing the image, according to new research.
Experimental drug improves survival rate of majority of lung cancer patients compared to standard chemotherapy
In global clinical trials, patients with advanced metastatic lung cancer who were treated with a targeted immunotherapy drug lived significantly longer and with fewer side effects than those who received standard second-line chemotherapy, according to a new Kaiser Permanente study published today in the journal The Lancet.
› Verified 9 days ago